Preferences help
enabled [disable] Abstract
Number of results
2010 | 57 | 4 | 499-503
Article title

Methotrexate binding causes structural and functional changes in lung cystatin

Title variants
Languages of publication
Regulation of cysteine proteinases and their inhibitors is of utmost importance in diseases like lung cancer, chronic inflammatory conditions such as asthma, emphysema, and idiopathic pulmonary fibrosis. Protease-antiprotease imbalance accelerates disease progression. In the present study, the effect of antineoplastic and antirheumatic drug methotrexate (MTX) on lung cystatin (a cysteine protease inhibitor) was studied to explore drug induced changes in functional and structural integrity of the protein. The basic binding interaction was studied by UV-absorption, FT-IR and fluorescence spectroscopy. The quenching of protein fluorescence confirmed the binding of MTX with goat lung cystatin (GLC-I). Stern-Volmer analysis of MTX-GLC-I system at different temperatures indicates the presence of static component in the quenching mechanism. The thermodynamic parameters ΔH0 and ΔS0 were -3.8 kJ/mol and 94.97 J•mol-1•K-1, respectively, indicating that both hydrogen bonds and hydrophobic interactions played a major role in the binding of MTX to GLC-I. Methotrexate (7 µM) caused complete inactivation of lung cystatin after 6 hours. The results of FT-IR spectroscopy reflect perturbation of the goat lung cystatin on interaction with MTX. Methotrexate induced loss of function change in the inhibitor could provide a rationale for the off target tissue injury caused by the drug and for the design of agents against such an injury.
Physical description
  • Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, U.P., India
  • Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, U.P., India
  • Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, U.P., India
  • Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, U.P., India
  • Assfalg-Machleidt I, Jochum M, Klaubert W et al. (1998) Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors. Biol Chem Hoppe-Seyleri 369: 263-269.
  • Bernstein HG, Kirschke H, Wiederander B et al. (1996) The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease. Mol Chem Neuropathol 27: 225-247.
  • Bures L, Lichy A, Bostik J, Spundova M (1990) The use of protein as a carrier of methotrexate for experimental cancer therapy. V. Alternative method for preparation of serum albumin-methotrexate derivative. Neoplasma 37: 225-231.
  • Buttle DJ, Burnett D, Abrahamson M (1990) Levels of neutrophil elastase and cathepsin B activities and cystatins in human sputum: relathioship to inflammation. Scand J Clin Lab Invest 50: 509-516.
  • Cui FL, Fan J, Li JP, Hu Z (2004) Interactions between 1-benzoyl-4-p-chlorophenyl thiosemicarbazide and serum albumin: Investigation by fluorescence spectroscopy. Bioorg Med Chem 12: 151-157.
  • Delaisse JM, Ledent P, Vaes G (1991) Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L- like 70 kDa proteinase. Biochem J 279: 167-174.
  • Ekiel I, Abrahamson M, Fulton D et al. (1997) NMR structural studies of human cystatin C dimers and monomers. J Mol Biol 271: 266-277.
  • Feng XZ, Lin Z, Yang LJ, Wang C, Bai CL (1998) Investigation of the interaction between acridine orange and bovine serum albumin. Talanta 47: 1223-1229.
  • Gao H, Lei L, Liu J, Quin K, Chen X, Hu Z (2004) The study on the interaction between serum albumin and a new reagent with antitumour activity by spectrophotometric methods. J Photochem Photobiol 167: 213-221.
  • Hu YJ, Liu Y, Wang JB, Xiao XH, Qu SS (2004) Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. J Pharm Biomed Anal 36: 915-919.
  • Hughes WT, Rivera G, Schell M et al. (1987) Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 316: 1627-1632.
  • Jensson O, Palsdottir A, Thorsteinsson L et al. (1990) Cystatin C mutation causing amyloid angiopathy and brain hemorrhage. Biol Chem Hoppe-Seyler 371: 229-232.
  • Kabanda A, Goffin E, Bernard A (1995) Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 48: 1946-1952.
  • Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157: 1301-1315.
  • Khan MS, Bano B (2009) Purification, characterization and kinetics of thiol protease inhibitor from goat (Capra hircus) lung. Biochemistry (Moscow) 74: 781-788.
  • Kopper P, Baici A, Keist R et al (1994) Cathepsin B-like proteinase as a marker for metastatic tumors cell variants. Exp Cell Biol 52: 293-299.
  • Kunitz M (1947) Crystalline soybean trypsin inhibitor : II. General Properties. J Gen Physiol 30: 291-310.
  • Neves C, Jorge R, Barcelos A (2009) The network of methotrexate toxicity. Acta Reumatol Port 34: 11-34.
  • North MJ, Moltram, JC, Coombs GH (1990) Cysteine proteinases of parasitic protozoa. Parasitol Today 6: 270-275.
  • Russell RE, Thorley A, Culpitt SV et al. (2002) Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 283: L867-873.
  • Scheiber J, Chen B, Milik M, Sukuru SCK, Bender A, Mikhailov D et al. (2009) Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inf Model 49: 308-317.
  • Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104: 1191-1197.
  • Sneppen K, Zocchi G (2005) Physics in molecular biology. Cambridge University Press, Cambridge, UK.
  • Takeda K, Wada A, Yamamoto K, Hachiya K, Batra PP (1998) Secondary structure change of myoglobin induced by sodium dodecyl sulfate and its kinetic aspects. J Colloid Interface Sci 125: 307-313.
  • Taniguchi CM, Armstrong SR, Green LC, Goaln DE, Tashjian AH Jr (2007) Fundamental principles of pharmacology. Chapter 5: pp 63-73. Wolters Kluwer, Lippincott Williams and Wilkins.
  • Trabandt A, Gay RE, Gay RS (1991) Cathepsin B in synovial cell at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 34: 1444-1451.
  • Turk V, Stoka V, Turk D (2008) Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 13: 5406-5420.
  • Wang Z, Zheng T, Zhu Z et al. (2000) Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192: 1587-1600.
  • Surewicz WK, Mantsch HH, Chapman D (1993) Determination of protein secondary structure by Fourier-transform infrared spectroscopy: a critical assessment. Biochemistry 32: 389-394.
  • Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese Jr RJ, Chapman Jr HA, Shapiro SD, Elias JA (2000) Inducible targeting of Il-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema. J Clin Invest 106: 1081-1093.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.